France implements smoking ban at beaches and parks in step towards ‘tobacco-free generation'
Anyone who lights up on a beach or in a public park in France will be breaking the law from Sunday under new rules aimed at protecting children from the dangers of passive smoking.
Bus shelters and areas in the immediate vicinity of libraries, swimming pools and schools will also be affected by the ban, which is coming into force one day after its publication in the official government gazette on Saturday.
The rule is being imposed one week before the beginning of the school holidays in France in a bid to immediately protect children from smoke on the beach.
However, to the disappointment of some anti-tobacco activists, the ban does not cover the terraces of bars and restaurants where many French still happily smoke.
They are also unhappy that the ban does not apply to electronic cigarettes.
The rules had initially been expected to come into force on Tuesday after a previous announcement by the health ministry but the publication in the official gazette means this has now been brought forward to Sunday.
People should also not smoke within 10 metres of schools, swimming pools, libraries and other places where smoking could hurt minors.
The health ministry said it would soon reveal the sign used to designate such areas.
Violators of the ban could face a fine of 135 euros ($160) up to a maximum of 700 euros.
'Tobacco must disappear from places where there are children. A park, a beach, a school – these are places to play, learn, and breathe. Not for smoking,' health and family minister Catherine Vautrin said.
This is another step 'towards a tobacco-free generation', she added, which France is targeting from 2032.
Yves Martinet, president of the National Committee Against Smoking (CNCT), said the ban was 'a step in the right direction, but remains insufficient', criticising the continued permission to smoke on cafe terraces.
'The minister points to the protection of children,' but children 'also go to the terraces', said Martinet, who is a pulmonologist.
He lamented the absence of e-cigarettes from the text, saying flavours are used to 'hook young people'.
But Frank Delvau, president of the Union of Hotel Trades and Industries (UMIH) for the Paris region, said a ban on smoking on cafe terraces 'would only shift the problem because people on terraces would go smoke next to these establishments'.
Franck Trouet, of the hospitality association Hotels and Restaurants of France (GHR), said 'smokers and non-smokers can coexist' on terraces, the 'last places of conviviality and freedom'.
In France, passive exposure to tobacco smoke causes 3,000 to 5,000 deaths per year, according to official figures.
Smoking is steadily declining in France with 'the lowest prevalence ever recorded since 2000', according to France addiction agency the OFDT.
Less than a quarter of adults aged 18 to 75 reported smoking daily in 2023, according to the agency. Smoking causes 75,000 deaths per year in France and, again according to the OFDT, costs society 156bn euros annually, counting factors including lost lives, quality of life, productivity, prevention, law enforcement and healthcare.
According to a recent opinion survey, 62% of French people favour a smoking ban in public places.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
ASL Strategic Value Fund targets Avadel board over Lumryz drug mismanagement, WSJ reports
June 29 (Reuters) - ASL Strategic Value Fund plans to push shareholders of drugmaker Avadel Pharmaceuticals (AVDL.O), opens new tab to vote to remove the company's board, citing mismanagement in the launch of its flagship sleep disorder drug, the Wall Street Journal reported on Sunday. The fund, which holds shares worth about $15 million in Avadel, plans to publish an open letter arguing that the mismanagement in the launch of the drug called Lumryz resulted in the company missing out on hundreds of millions of dollars in revenue, the report said, citing a copy of the letter. The investment firm also reiterated a call to the Ireland-based drugmaker to hire an investment bank and explore alternatives including a sale, the report added. Reuters could not independently establish the veracity of the report. Avadel and ASL did not immediately respond to Reuters' requests for comment. Last year, the U.S. Food and Drug Administration approved Lumryz for children aged 7 years and older who presented with sudden muscle weakness, called cataplexy, or excessive daytime sleepiness, both symptoms of the sleep disorder called narcolepsy. Narcolepsy is a chronic neurological disorder that impacts the brain's ability to regulate sleep and wake cycles, with 70% of patients also experiencing cataplexy.
Daily Mail
3 hours ago
- Daily Mail
EXCLUSIVE I was thrilled after I lost a stone-and-a-half on Ozempic... then I was hit by this common side-effect. This is the revolutionary new tool that changed everything: OLIVIA FALCON
Like thousands of other menopausal women (I'm 51 now), my health and my figure have been transformed by weight-loss injections. I started using Ozempic in April 2023 and I was thrilled to lose a stone-and-a-half in nine months – I now microdose Mounjaro to maintain my weight.
Daily Mail
4 hours ago
- Daily Mail
Sperm from men over the age of 45 are linked to higher IVF miscarriages and lower birth rates - even when young donor eggs were used
IVF involving men over the age of 45 is linked to increased miscarriage risks, a study has revealed. Researchers found that a man's age plays a significant role in their reproductive success, challenging the notion that sperm age has little impact once fertilisation has occurred. They discovered that sperm from older men also led to lower live birth rates – even when young donor eggs were used. And experts said their results should be considered during the IVF counselling process between doctors and patients. The study, published in the journal Human Reproduction, analysed 1,712 egg donation cycles between 2019 and 2023 across six IVF centres in Italy and Spain. All cycles used fresh donor eggs with an average donor age of 26 and frozen sperm from male partners. The fertilised eggs were then transferred to the intended mothers, who had an average age of 43. Participants were divided into two groups – men aged 45 or younger and those over 45, and while fertilisation rates and embryo development were similar between the groups, differences emerged in the outcomes of the pregnancies. Miscarriage rates – where the baby is lost before 24 weeks – were notably higher among couples where the male partner was over 45, reaching 23.8 per cent compared with 16.3 per cent in the younger paternal age group. IVF involving men over the age of 45 is linked to increased miscarriage risks, a study has revealed Live birth rates were also lower in the older paternal age group, at 35.1 per cent versus 41 per cent for men aged 45 or younger. Discussing the findings, Dr Maria Cristina Guglielmo, an embryologist at the fertility clinic Eugin Italy, said: 'Traditionally, maternal age has been the central focus in reproductive medicine, but our results show that the age of the male partner also plays a crucial and independent role.' She explained that as men age, the continuous division of sperm stem cells increases the chance of DNA replication errors. In turn, this can impair embryo development and contribute to a higher risk of miscarriage, she said. Dr Guglielmo added: 'Our findings underscore the need for fertility clinics to adopt a more balanced approach that recognises the role of paternal age. 'Clinics should ensure male patients are informed about how advancing paternal age can impact fertility potential, pregnancy success and miscarriage risk.'
